Terbutaline

Terbutaline
Systematic (IUPAC) name
5-(1-hydroxy-2-tert-butylamino-ethyl)benzene-1,3-diol
Identifiers
CAS number	23031-25-6
ATC code	R03AC03 R03CC03
PubChem	5403
DrugBank	APRD00589
Chemical data
Formula	C12H19NO3
Mol. mass	225.284 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	GI tract (oral), liver; CYP450: unknown
Half life	urine 90% (60% unchanged), bile/faeces; Half-life: 3-4h
Excretion	?
Therapeutic considerations
Pregnancy cat.	B
Legal status	POM(UK)
Routes	SQ, Oral, Inhaled

WikiDoc Resources for Terbutaline
Articles
Most recent articles on Terbutaline Most cited articles on Terbutaline Review articles on Terbutaline Articles on Terbutaline in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Terbutaline Images of Terbutaline Photos of Terbutaline Podcasts & MP3s on Terbutaline Videos on Terbutaline
Evidence Based Medicine
Cochrane Collaboration on Terbutaline Bandolier on Terbutaline TRIP on Terbutaline
Clinical Trials
Ongoing Trials on Terbutaline at Clinical Trials.gov Trial results on Terbutaline Clinical Trials on Terbutaline at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Terbutaline NICE Guidance on Terbutaline NHS PRODIGY Guidance FDA on Terbutaline CDC on Terbutaline
Books
Books on Terbutaline
News
Terbutaline in the news Be alerted to news on Terbutaline News trends on Terbutaline
Commentary
Blogs on Terbutaline
Definitions
Definitions of Terbutaline
Patient Resources / Community
Patient resources on Terbutaline Discussion groups on Terbutaline Patient Handouts on Terbutaline Directions to Hospitals Treating Terbutaline Risk calculators and risk factors for Terbutaline
Healthcare Provider Resources
Symptoms of Terbutaline Causes & Risk Factors for Terbutaline Diagnostic studies for Terbutaline Treatment of Terbutaline
Continuing Medical Education (CME)
CME Programs on Terbutaline
International
Terbutaline en Espanol Terbutaline en Francais
Business
Terbutaline in the Marketplace Patents on Terbutaline
Experimental / Informatics
List of terms related to Terbutaline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Terbutaline (trade names Brethine, Bricanyl, or Brethaire) is a β₂-adrenergic receptor agonist, used as a fast-acting bronchodilator (often used as a short-term asthma treatment) and as a tocolytic to delay premature labour. The inhaled form of terbutaline starts working within 15 minutes and can last up to 6 hours.

Terbutaline as a treatment for premature labour is an off-label use not approved by the FDA. It is a pregnancy category 'B' medication and is routinely prescribed to stop contractions.

Side Effects

Maternal - tachycardia, nervousness, tremors, headache and possible pulmonary edema. Fetal - tachycardia and hypoglycemia. Terbutaline is preferred over Ritodrine because it has minimal effects on blood pressure.

References

da:Terbutalin